Clinuvel Pharmaceuticals (CLVLF) Q1 2024 Earnings

22FebConfirmed
Q3 2022
Q1 2023
Q3 2023
Q1 2024
0.14
0.17
0.21
0.24

Details

Expected EPS
N/A
Actual EPS
0.1377369
Surprise EPS
0.14
Surprise Percent
+∞%

Description

Clinuvel Pharmaceuticals (CLVLF) has reported earnings of 0.1377369 per share for Q1 2024.

0 Comments

Share your thoughts